Gannett Co., Inc. Common Stock (GCI)
3.9050
+0.0950 (2.49%)
NYSE · Last Trade: Aug 1st, 1:04 PM EDT
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · July 15, 2025
Via Benzinga · April 17, 2025

The U.S. Department of Justice sued Alphabet, claiming the tech giant used monopolistic practices to dominate the search engine business with Google.
Via The Motley Fool · September 28, 2024

Via Benzinga · September 18, 2024

Analysts at Citigroup placed Gannett on a "90-day positive catalyst watch" this morning.
Via The Motley Fool · September 17, 2024

Via Benzinga · September 17, 2024

According to predictive markets, presidential election odds are favoring a Kamala Harris victory. Here's what this means for investors.
Via InvestorPlace · August 9, 2024

Google reverses plan to eliminate cookies in Chrome due to industry and regulatory pressure. Users will now choose to enable or disable cookies.
Via Benzinga · July 23, 2024

Gannett's stock could trade closer to peer multiples with digital revenue growth and margin expansion.
Via Benzinga · July 1, 2024

Via Benzinga · June 17, 2024

Via Benzinga · May 24, 2024

Via Benzinga · May 24, 2024

GCI stock results show that Gannett Co beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 2, 2024

Via Benzinga · May 2, 2024

Sports Illustrated, under new ownership sees a revitalizing publishing deal with Minute Media, promising a fresh start and continuity.
Via Benzinga · March 20, 2024

Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-
Via Benzinga · February 14, 2024

As of Dec. 13, 2023, five stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via Benzinga · December 13, 2023

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.
Via Benzinga · December 26, 2023